Side Effects & Safety Contraindications Active cancer or pre-cancerous conditions (p53-modulating agents require extreme caution) Impaired wound healing or active wounds (senescent cells play roles in wound repair) Pregnancy or breastfeeding (no safety data) Immune-compromised individuals (unknown effects on immune senescence) p53 mutations or Li-Fraumeni syndrome (mechanism requires functional p53) Interactions Chemotherapy agents (may enhance clearance of treatment-induced senescent cells but could also affect treatment efficacy) Other senolytic compounds such as dasatinib + quercetin (potential additive effects caution warranted) Immunosuppressive drugs (may alter the immune response to cleared senescent cells) Reconstitution & Storage Related Peptides FOXO4-DRI addresses aging at the cellular senescence level, complementing other longevity-targeted peptides that work through different mechanisms
112 Dulaglutide is a once-weekly long-acting GLP-1RA
Szweda, Bertrand Friguet, Age-Dependent Declines in Proteasome Activity in the Heart, Archives of Biochemistry and Biophysics, Volume 397, Issue 2, 2002, Pages 298-304, ISSN 0003-9861, Murtaza G, Khan AK, Rashid R, Muneer S, Hasan SMF, Chen J
If the vial has been refrigerated, let it warm up for a few minutes before injecting to reduce sting
Our local clients appreciate: Thoughtfully stacked peptides paired with IV therapy, lifestyle support, or hormone optimization Concierge support from our wellness team Ongoing monitoring and lab work as needed While peptide therapy is still emerging in mainstream medicine, the research is growing
Wang Z, Tan W, Zhang P, Xiong H, Zhu L, Cui J, et al
